Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies. | Heliyon | 2023 | 37829813 | PubTator, text mining | PubMed |
| Retracted: N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM). | Biomed Res Int | 2023 | 37829051 | PubTator, text mining | PubMed |
| Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis. | Mol Cell Proteomics | 2023 | 37820923 | PubTator, text mining | PubMed |
| An immune and epigenetics-related scoring model and drug candidate prediction for hepatic carcinogenesis via dynamic network biomarker analysis and connectivity mapping. | Comput Struct Biotechnol J | 2023 | 37817777 | PubTator, text mining | PubMed |
| N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin. | Kurume Med J | 2023 | 37793886 | PubTator, text mining | PubMed |
| Hydrostatic pressure under hypoxia facilitates fabrication of tissue-engineered vascular grafts derived from human vascular smooth muscle cells in vitro. | Acta Biomater | 2023 | 37793599 | PubTator, text mining | PubMed |
| Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer. | Front Pharmacol | 2023 | 37781691 | PubTator, text mining | PubMed |
| Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. | Cell Death Dis | 2023 | 37775701 | PubTator, text mining | PubMed |
| Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases. | Medicina (Kaunas) | 2023 | 37763671 | PubTator, text mining | PubMed |
| Targeting Breast Cancer: The Familiar, the Emerging, and the Uncharted Territories. | Biomolecules | 2023 | 37759706 | PubTator, text mining | PubMed |
| Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives. | Biomolecules | 2023 | 37759686 | PubTator, text mining | PubMed |
| Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy. | Blood | 2023 | 37756525 | PubTator, text mining | PubMed |
| Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view. | Reprod Biol Endocrinol | 2023 | 37749573 | PubTator, text mining | PubMed |
| The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation. | Nucleic Acids Res | 2023 | 37739411 | PubTator, text mining | PubMed |
| Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach. | Cell Rep Med | 2023 | 37738978 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals That Adaptation of Human Aortic Endothelial Cells to Antiproliferative Therapies Is Modulated by Flow-Induced Shear Stress. | Arterioscler Thromb Vasc Biol | 2023 | 37732484 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. | Sci Rep | 2023 | 37717078 | PubTator, text mining | PubMed |
| Deep dissection of stemness-related hierarchies in hepatocellular carcinoma. | J Transl Med | 2023 | 37717019 | PubTator, text mining | PubMed |
| Carcinogen-induced super-enhancer RNA promotes nasopharyngeal carcinoma metastasis through NPM1/c-Myc/NDRG1 axis. | Am J Cancer Res | 2023 | 37693164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=13